Prof Friedrich Thienemann

Head: GMGH

Internal Medicine & Infectious Diseases Specialist, DTMPH, MSc International Health
 
CHI research groups: General Medicine & Global Health (GMGH) (Lead) | Heart of Africa
CHI membership: Full member

Friedrich Thienemann undertook his post-graduate training in internal medicine, infectious diseases, tropical medicine and global health at Charité University Hospital Berlin and the University of Cape Town. In 2009, he joined the Department of Medicine and Institute of Infectious Disease and Molecular Medicine at the University of Cape Town and served as an investigator of several EU, NIH and university-funded projects and successfully administered multi-national, multi-site clinical trials and cohort studies across Africa. In 2019, Friedrich Thienemann established the research group General Medicine & Global Health (GMGH) with two sites, at the University of Zurich and the Cape Heart Institute of the University of Cape Town. His work is on optimising the diagnosis and treatment of tuberculosis, understanding the intersection of infectious and cardiovascular disease and the role of molecular imaging in infective lung disease. He lives between Zurich and Cape Town.

Research engagements:

  • Understanding tuberculosis and HIV-associated to pulmonary hypertension (PAPCUO II)
  • Preventing tuberculosis relapse and chronic lung disease (StatinTB) 
  • Shortening tuberculosis treatment duration (PredictTB)
  •  Tuberculosis treatment shortening trials with for new drugs (PAN-TB)
  • Tuberculosis vaccine discovery and clinical testing
  • Spectrum of disease and gene expression signature of spinal tuberculosis